Design, characterization and anti-tumour cytotoxicity of a panel of recombinant, mammalian ribonuclease-based immunotoxins
1998

Immunotoxins from Bovine Seminal Ribonuclease

publication Evidence: moderate

Author Information

Author(s): MP Deonarain, AA Epenetos

Primary Institution: Imperial College School of Medicine at the Hammersmith Hospital

Hypothesis

Can we enhance the anti-tumor activity of bovine seminal ribonuclease through targeted immunotoxins?

Conclusion

The study successfully developed immunotoxins that are significantly more cytotoxic to cancer cells than native bovine seminal ribonuclease.

Supporting Evidence

  • The immunotoxins showed over 2 x 10^4-fold increased cytotoxicity compared to native bovine seminal ribonuclease.
  • The addition of a KDEL sequence significantly improved cytotoxicity.
  • Immunotoxins were more toxic to PLAP-positive cells than to PLAP-negative cells.

Takeaway

Scientists created special proteins that can kill cancer cells better than a natural protein from bull semen. They made these proteins stick to cancer cells to work better.

Methodology

The study involved constructing, expressing, purifying, and characterizing various immunotoxins based on bovine seminal ribonuclease.

Limitations

The immunotoxins produced were mainly aggregates and monomers, making it difficult to determine the contribution of dimeric binding to cytotoxicity.

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication